Keywords: USA, Biotech share performance, Biosimilars, Burrill & Co, M&A activity,

US biotech sector besieged by debt worries, political dysfunction in 3rd-qtr, says Burrill

Article | 06 October 2011

The fight in the USA over the raising of the debt ceiling and the debt crisis in Europe have fueled ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in